Pfizer Ventures

Investor type

CVC

Founded

1884

AUM

$600 M

Location

New York, New York, United States

Investment Ticket

$5-10 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

Europe North America Asia Australia and others
Investor profile last updated: 21 August, 2026

Profile

Pfizer Ventures is the strategic corporate venture capital arm of Pfizer, headquartered in the United States. It operates a global network and is composed of skilled professionals who bring scientific insight and strategic guidance to their portfolio companies. Pfizer Ventures distinguishes itself by providing not only capital but also strategic support and access to Pfizer's expansive expertise, aiding companies in their scaling processes.

Industry

Healthcare Services Software MedTech Biotechnology HealthTech Life Sciences Medical Devices

Pfizer Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Pfizer Venture Investments Fund I
Corporate VC (CVC)
Healthcare Services
Medical Devices
Life Sciences
Seed
Series A
Series B
North America
Europe
Asia
$5-10 m
$600 M
June 2018

Contacts

Name
Title
Email
avatar
Albert Bourla Chief Executive Officer
Chief Executive Officer
r•••@•••
avatar
Susanne Lang In Vivo Immunologist / Principal Scientist
In Vivo Immunologist / Principal Scientist
s•••@•••
Upgrade to see contacts
avatar
howQsK0WRStxYbjJ howQsK0WRStxYbjJ
howQsK0WRStxYbjJ
avatar
howQsK0WRStxYbjJ howQsK0WRStxYbjJ
howQsK0WRStxYbjJ
avatar
howQsK0WRStxYbjJ howQsK0WRStxYbjJ
howQsK0WRStxYbjJ
Investment-team contacts for Pfizer Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Pfizer Ventures

Pfizer Ventures operates as a corporate VC (CVC). It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $5-10 m.
Pfizer Ventures is located in New York, New York, United States.
Pfizer Ventures was founded in 1884.
Pfizer Ventures invests in companies and startups in Healthcare Services, Software, MedTech, Biotechnology, HealthTech, Life Sciences, Medical Devices.
Pfizer Ventures invests in companies and startups in Europe, North America, Asia, Australia and others.
Pfizer Ventures invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).
Pfizer Ventures usually invests $5-10 m on average.
Pfizer Ventures has around $600m assets under management.
Pfizer Ventures last fund was created/launched in 2018-06-06
Pfizer Ventures can be reached through its website pfizer.com/partners/venture-investments, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Pfizer Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Pfizer Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.